Mirion ("we" or the "company") (NYSE: MIR), a leading provider of radiation safety solutions supporting advancements in nuclear power and cancer care, will host an Investor Day today, December 3, 2024 ...
Among the different strategies employed to control mucositis/stomatitis are anti-inflammatory agents ... ongoing approaches to the management of radiation-induced mucositis are discussed below.
NAFDAC also disclosed where the fake anti-malarial medicine was discovered. The National Agency for Food and Drug Administration and Control (NAFDAC) has raised the alarm regarding the circulation ...
Experts from Duke Cancer Institute discuss the creation of individualized management plans to transition patients from oncologist to primary care physician. Beyond Cancer: A Multidisciplinary ...